Skip to main content
Department of Biochemistry and Molecular Medicine

Department of Biochemistry and Molecular Medicine

News releases

August 2015arrow

UC Davis researchers receive $5.4 million grant to study new tool to evaluate early-stage Alzheimer's

August 31, 2015

Alzheimer’s researchers at UC Davis and UC San Diego have launched a new study which aims to detect the earliest stages of cognitive dysfunction in people with pre-clinical Alzheimer’s disease by using event-related brain potentials (ERPs).

New York Blood Center partners with UC Davis Health System to produce more viable stem cell therapies

August 20, 2015

New York Blood Center (NYBC) today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

UC Davis team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.

UC Davis to employ canines to sniff out cancer

August 17, 2015

UC Davis clinicians are hoping to greatly advance cancer screenings with the innate olfactory skills of man’s best friend.

A better way to personalize bladder cancer treatments

August 13, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

New UC Davis environmental research center links science with advocacy

August 12, 2015

A cross-disciplinary center focused on identifying connections between environmental toxins and disease has been established at UC Davis Health System with the ultimate goal of developing preventions and policies that protect communities from unhealthy exposures.

New combination treatment effective against melanoma skin metastases

August 11, 2015

mIn findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.

Using kidneys from very small donors for transplant is safer than expected

August 10, 2015

Kidneys transplanted from infants who died of birth-related or other complications are less likely to fail due to a post-surgical vascular complication known as graft arterial stenosis (GAS) than kidneys from deceased adults, resesarchers have found.

UC Davis clinical research scientist wins second Hartwell Foundation award for pediatric cancer research

August 7, 2015

UC Davis pediatric oncologist and researcher Noriko Satake has been awarded a 2015 Hartwell Biomedical Research Collaboration Award from The Hartwell Foundation, a philanthropy that funds innovative and leading-edge biomedical research with the potential to benefit children of the United States. This is the first time a Hartwell investigator from UC Davis has received the Foundation’s inter-institutional Collaboration Award.

Cherry lands top NCI grant

August 6, 2015

Simon Cherry, distinguished professor in the departments of Biomedical Engineering and Radiology, and co-leader of the UC Davis Comprehensive Cancer Center’s Biomedical Technology Program, has been selected to receive a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).

Raising pay can reduce smoking rates

August 6, 2015

In addition to restricting when and where tobacco is used at work, UC Davis Health System research shows that employers can do something else to reduce the number of employees who smoke: raise wages.

Long-term ovarian cancer survival higher than thought

August 5, 2015

Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.

July 2015arrow

Waking up HIV

July 30, 2015

Highly active anti-retroviral therapy (HAART) has helped millions survive the human immunodeficiency virus (HIV). Unfortunately, HIV has a built-in survival mechanism, creating reservoirs of latent, inactive virus that are invisible to both HAART and the immune system.

Consuming highly refined carbohydrates increases risk of depression

July 30, 2015

A diet high in refined carbohydrates may lead to an increased risk for new-onset depression in postmenopausal women, according to a study published in The American Journal of Clinical Nutrition. [en español]

UC Davis offers stroke-prevention alternative for patients with atrial fibrillation

July 29, 2015

Cardiologists at UC Davis are the first in Northern California to treat the major risk of stroke that comes with atrial fibrillation (AF), the most common form of arrhythmia, with a device that blocks blood clots from traveling from the heart to the head.

Autism costs estimated to reach nearly $500 billion, potentially $1 trillion, by 2025

July 28, 2015

UC Davis health economists have for the first time projected the total costs of caring for all people with autism spectrum disorder (ASD) in the U.S. for the current calendar year and in 10 years if effective interventions and preventive treatments for the condition are not identified and widely available.

UC Davis researchers awarded grant for HIV clinical trial using stem cells

July 23, 2015

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease.

UC Davis researchers identify the source of the debilitating memory loss in people with psychosis

July 22, 2015

As disabling as its delusions and hallucinations, psychosis’ devastating toll on memory arises from dysfunction of frontal and temporal lobe regions in the brain that rob sufferers of the ability to make associative connections, a UC Davis study has found, pinpointing potential target areas for treatments to help the more than 3.2 million Americans for whom medication quells the voices and visions, but not the struggle to remember. [en español]

UC Davis researcher receives grant to study psoriatic arthritis

July 20, 2015

Iannis Adamopoulos, a researcher dedicated to studying diseases of the immune and skeletal systems, has received a $200,000 grant from the National Psoriasis Foundation to improve treatments for psoriatic arthritis.

Rogawski receives 2015 Neuroendocrine Research Award from the American Academy of Neurology

July 9, 2015

Michael Rogawski, professor of neurology at UC Davis, recently was awarded the 2015 Neuroendocrine Research Award at the 67th Annual American Academy of Neurology meeting in Washington, D.C.

New medical school admission process doesn't reduce diversity

July 8, 2015

Under-represented minorities fare as well as others in an increasingly popular method of selecting medical school students known as the Multiple Mini Interview, or MMI, according to new research from the UC Davis School of Medicine.

UC Davis study identifies tools, strategies for enhancing obesity prevention in rural communities

July 7, 2015

Researchers at UC Davis have reviewed a successful telemedicine intervention against pediatric obesity to better understand what worked (or didn’t) and how similar programs can be improved.

UC Davis researchers find key mechanism that causes neuropathic pain

July 6, 2015

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.